Drug
Cisplatin
Cisplatin: highest development phase Phase 3, developed by BioMarin Pharmaceutical, Chugai. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical, Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| cisplatin NCT00470223 | Phase 3 | Sarcoma |
| Cisplatin NCT02537561 | Phase 1 | Solid Tumors |
Latest
No recent events.
Follow Cisplatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.